Hubei Guangji Pharmaceutical Co Ltd (000952) — Cash Flow Reinvestment Rate
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥8.67 Million (capex CN¥8.67 Million ) from operating cash flow of CN¥22.38 Million. Explore how much does Hubei Guangji Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Hubei Guangji Pharmaceutical Co Ltd across 19 annual periods. Also explore 000952 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hubei Guangji Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for Hubei Guangji Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Hubei Guangji Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 469.53x | CN¥307.71 Million | CN¥655.36K | CN¥154.93 Million | ▲ +7360.6% |
| 2022 | 6.29x | CN¥283.71 Million | CN¥45.08 Million | CN¥203.71 Million | ▲ +309.7% |
| 2021 | 1.54x | CN¥116.61 Million | CN¥75.91 Million | CN¥96.61 Million | ▲ +16.1% |
| 2020 | 1.32x | CN¥157.89 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.1% |
| 2019 | 1.25x | CN¥179.76 Million | CN¥144.20 Million | CN¥119.76 Million | ▲ +111.3% |
| 2018 | 0.59x | CN¥136.53 Million | CN¥231.44 Million | CN¥76.53 Million | ▼ -25.1% |
| 2017 | 0.79x | CN¥140.91 Million | CN¥178.83 Million | CN¥80.91 Million | ▼ -40.7% |
| 2016 | 1.33x | CN¥222.03 Million | CN¥167.07 Million | CN¥112.94 Million | ▲ +152.7% |
| 2013 | 0.53x | CN¥50.04 Million | CN¥95.16 Million | CN¥50.04 Million | ▼ -51.6% |
| 2012 | 1.09x | CN¥117.46 Million | CN¥108.02 Million | CN¥117.46 Million | ▼ -55.7% |
| 2011 | 2.45x | CN¥200.96 Million | CN¥81.88 Million | CN¥200.96 Million | ▲ +63.9% |
| 2010 | 1.50x | CN¥115.57 Million | CN¥77.18 Million | CN¥115.57 Million | ▲ +50.4% |
| 2008 | 1.00x | CN¥219.76 Million | CN¥220.70 Million | CN¥219.76 Million | ▲ +575.4% |
| 2007 | 0.15x | CN¥48.94 Million | CN¥331.98 Million | CN¥48.94 Million | ▼ -0.9% |
| 2006 | 0.15x | CN¥18.73 Million | CN¥125.95 Million | CN¥18.73 Million | ▼ -68.8% |
| 2005 | 0.48x | CN¥25.84 Million | CN¥54.14 Million | CN¥25.84 Million | ▼ -28.0% |
| 2002 | 0.66x | CN¥50.52 Million | CN¥76.20 Million | CN¥50.52 Million | ▲ +28.3% |
| 2000 | 0.52x | CN¥25.11 Million | CN¥48.57 Million | CN¥25.11 Million | ▼ -73.9% |
| 1999 | 1.98x | CN¥135.58 Million | CN¥68.57 Million | CN¥135.58 Million | — |